CC-401

DB12432InvestigationalSmall molecule

CC-401 has been used in trials studying the treatment of Myeloid Leukemia.

Mechanism: Pharmacologically active on Mitogen-activated protein kinase 10, Mitogen-activated protein kinase 9, and Mitogen-activated protein kinase 8
Curator reviewed
Formula / weight: C₂₂H₂₄N₆O · 388.475 g/mol (avg)
Code names: CC-401

Resolves to

Compound

Structure

InChIKeyXDJCLCLBSGGNKS-UHFFFAOYSA-NSMILESC(CN1CCCCC1)OC1=CC=CC(=C1)C1=NNC2=CC=C(C=C12)C1=NNC=N1

Targets

What you can answer from here — as of June 15, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

9+ReferencesStructured and connected to the statements they support

Which drugs share a target with CC-401, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.